Verve Therapeutics Inc [VERV] Shares Fall Approximately -58.93% Over the Year
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Verve Therapeutics Inc shares valued at $12,475 were sold by Nickerson Joan on Apr 02 ’24. At $8.24 per share, Nickerson Joan sold 1,514 shares. The insider’s holdings dropped to 8,659 shares worth approximately […]
Taking a Closer Look At Verve Therapeutics Inc (VERV) Following Its Recent Trade
In a filing, Verve Therapeutics Inc revealed its Chief Administrative Officer Nickerson Joan unloaded Company’s shares for reported $12475.0 on Apr 02 ’24. In the deal valued at $8.24 per share,1,514 shares were sold. As a result of this transaction, Nickerson Joan now holds 8,659 shares worth roughly $57495.759999999995. Then, Dorval Allison sold 554 shares, […]
Verve Therapeutics Inc [VERV] Records 50-Day SMA of $12.42
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Verve Therapeutics Inc shares valued at $12,475 were sold by Nickerson Joan on Apr 02 ’24. At $8.24 per share, Nickerson Joan sold 1,514 shares. The insider’s holdings dropped to 8,659 shares worth approximately $58361.66 following the […]
VERV’s latest rating updates from top analysts.
Verve Therapeutics Inc’s recently made public that its Chief Administrative Officer Nickerson Joan unloaded Company’s shares for reported $12475.0 on Apr 02 ’24. In the deal valued at $8.24 per share,1,514 shares were sold. As a result of this transaction, Nickerson Joan now holds 8,659 shares worth roughly $65808.4. Then, Dorval Allison sold 554 shares, […]
Insider Selling: Nickerson Joan, Verve Therapeutics Inc [VERV] Chief Administrative Officer divested 1,514 shares
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Verve Therapeutics Inc shares valued at $12,475 were sold by Nickerson Joan on Apr 02 ’24. At $8.24 per share, Nickerson Joan sold 1,514 shares. The insider’s holdings dropped to 8,659 shares worth approximately […]
Insider Sale Alert: Verve Therapeutics Inc [VERV] – Is it Time to sell?
In a filing, Verve Therapeutics Inc revealed its Chief Administrative Officer Nickerson Joan unloaded Company’s shares for reported $12475.0 on Apr 02 ’24. In the deal valued at $8.24 per share,1,514 shares were sold. As a result of this transaction, Nickerson Joan now holds 8,659 shares worth roughly $73774.68. Then, Dorval Allison sold 554 shares, […]
VERV Stock Sees Decline of Approximately -31.90% in Last Five Days
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Verve Therapeutics Inc shares valued at $12,475 were sold by Nickerson Joan on Apr 02 ’24. At $8.24 per share, Nickerson Joan sold 1,514 shares. The insider’s holdings dropped to 8,659 […]
Taking a Closer Look At Verve Therapeutics Inc (VERV) Following Its Recent Trade
Verve Therapeutics Inc’s recent filing unveils that its Chief Financial Officer Dorval Allison unloaded Company’s shares for reported $6343.0 on Nov 29 ’23. In the deal valued at $11.45 per share,554 shares were sold. As a result of this transaction, Dorval Allison now holds 4,060 shares worth roughly $53916.799999999996. Canaccord Genuity initiated its Verve Therapeutics […]
A Guide To The Risks Of Investing In Verve Therapeutics Inc (VERV)
Verve Therapeutics Inc’s recent filing unveils that its Chief Financial Officer Dorval Allison unloaded Company’s shares for reported $6343.0 on Nov 29 ’23. In the deal valued at $11.45 per share,554 shares were sold. As a result of this transaction, Dorval Allison now holds 4,060 shares worth roughly $53429.6. Canaccord Genuity initiated its Verve Therapeutics […]
Analyzing Stock On Your Own: Verve Therapeutics Inc. (NASDAQ: VERV)
Verve Therapeutics Inc. (NASDAQ:VERV) does about 768.12K shares in volume on a normal day but saw 618802 shares change hands in Friday trading. The company now has a market cap of 1.30B USD. Its current market price is $21.10, marking an increase of 2.48% compared to the previous close of $20.59. The 52 week high […]
